Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here. 		You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
TOP SEARCHES: OCT // Canaloplasty // AMD
In this issue
• Light adjustable lenses
• Cornea transplants
• Value for money
• IOL accolade
• Glaucoma
• Retinal diseases
Survey

What factors have most influenced patient numbers in 2009?
Novartis

The poor economy 33%
Ageing population 67%

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Pamela Brook, editor.

Click here to contact Neil Hanley, sales manager.
 
DECEMBER 09, 2009
Light-adjustable lens surgery comes to the UK
Ophthalmic surgeon Bobby Qureshi is the first in the UK to implant light-adjustable lenses (LALs), which have the capacity to be altered after surgery to provide the best vision for each individual eye without glasses. More...
Producing corneas for human transplant
Northeastern University engineering professor Jeffrey Ruberti and his research colleagues are breaking new ground in the technique known as "hybrid tissue engineering" by attempting to combine cow tissue with human tissue to produce corneas for human transplant. More...
Novel scleral lens proves cost-effective
In the December issue of the American Journal of Ophthalmology Brandeis University researchers published a paper about the economic benefits of the highly precise scleral lens, to treat severe cornea or ocular surface disease, the Boston Ocular Surface Prosthesis (BOS-P). More...
60 years of pioneering IOL innovation
Rayner Intraocular Lens Limited, has marked a milestone with a celebration to honour the 60th anniversary of the implantation of the first intraocular lens (IOL) in a patient. The late Sir Harold Ridley implanted the first IOL on 29 November 1949 at St. Thomas Hospital in London. Due to the controversial nature of the surgery, this first surgery was conducted in almost total secrecy. More...
IVB combined with panretinal photocoagulation in the treatment of open angle neovascular glaucoma
Findings published in the European Journal of Ophthalmology have found that intravitreal bevacizumab (IVB) combined with panretinal photocoagulation in patients with open angle neovascular glaucoma (NVG) can reduce iris and angle neovascularization and temporarily inhibit further PAS formation. More...
Research grant for inherited retinal disease care
Fight for Sight has announced £500,000 funding for a new research programme to develop an optimal model of care services for patients with inherited retinal diseases. The five-year programme will be led by Professor Graeme Black, Director of the National Institute for Health Research Manchester Biomedical Research Centre, supported by Professor Tony Moore of Moorfields Eye Hospital and Miss Susie Downes of Oxford Eye Hospital. More...

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.